Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | CDK4 | P11802 | 2/20 | 0.40 |
| ▸ | CCND1 | P24385 | 2/20 | 0.40 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.40 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.40 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | CDK7 | P50613 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbon Dioxide SCHEMBL9270437 | 0.98 | CYP3A4 (0.44) | CYP3A4CA12CA2CA9ALDH1A1 | |
| SCHEMBL10615043 | 0.84 | TDP1 (0.54) | CYP3A4CA12CA2CA9ALDH1A1 | |
| SCHEMBL27873 | 0.84 | TDP1 (0.54) | CYP3A4CA12CA2CA9ALDH1A1 | |
| SCHEMBL27621561 | 0.81 | TDP1 (0.52) | CYP3A4ALDH1A1TDP1MAPK1TRPA1 | |
| Ethylene SCHEMBL10425506 | 0.79 | TDP1 (0.50) | CYP3A4ALDH1A1TDP1MAPK1TRPA1 | |
| SCHEMBL30940204 | 0.79 | CA12 (0.58) | CYP3A4CA12CA2CA9ALDH1A1 | |
| SCHEMBL5721846 | 0.79 | CA12 (0.58) | CYP3A4CA12CA2CA9ALDH1A1 | |
| SCHEMBL5721840 | 0.79 | CA12 (0.58) | CYP3A4CA12CA2CA9ALDH1A1 | |
| SCHEMBL9701237 | 0.78 | MIF (0.54) | CYP3A4CA12CA2CA9ALDH1A1 | |
| SCHEMBL30365208 | 0.77 | TDP1 (0.48) | CYP3A4CA12CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559455-B2 | Compound as a UBR box domain ligand | AUTOTAC INC. (KR) | 2026-02-24 | — | — | US | disclosed |
| US-20230174470-A1 | COMPOUND AS A UBR BOX DOMAIN LIGAND | AUTOTAC INC. (KR) | 2023-06-08 | — | — | US | disclosed |
| WO-2023074936-A1 | BIFUNCTIONAL COMPOUND USING UBR BOX DOMAIN-BINDING LIGAND | 주식회사 오토텍바이오 | 2023-05-04 | — | — | WO | disclosed |
| EP-4144722-A1 | COMPOUND AS UBR BOX DOMAIN LIGAND | Autotac Inc. (KR) | 2023-03-08 | — | — | EP | disclosed |
| CN-115715285-A | Compounds as UBR box domain ligands | 奧土择破利悟 | 2023-02-24 | — | — | CN | disclosed |
| CN-106810512-B | IDH2 mutant inhibitor and application thereof | 江苏省中医药研究院 | 2019-09-10 | — | — | CN | disclosed |
| CN-106810512-A | IDH2 mutant inhibitor and application thereof | 江苏省中医药研究院 | 2017-06-09 | — | — | CN | disclosed |
| US-8710049-B2 | Diaminocyclohexane compounds and uses thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130184262-A1 | DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2013-07-18 | — | — | US | disclosed |
| WO-2013012829-A1 | DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-01-24 | — | — | WO | disclosed |
| WO-2012177896-A1 | TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2012-12-27 | — | — | WO | disclosed |
| US-5237100-A | Fungicide intermediates | NIHON BAYER AGROCHEM K.K. (JP) | 1993-08-17 | — | — | US | disclosed |
| US-4857556-A | FUNGICIDES | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1989-08-15 | — | — | US | disclosed |
| EP-0113028-B1 | SUBSTITUED BENZYLCYCLOALKENYL UREA DERIVATIVES | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-04-30 | — | — | EP | disclosed |
| EP-0113028-A1 | Substitued benzylcycloalkenyl urea derivatives | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1984-07-11 | — | — | EP | disclosed |
| US-4131751-A | PHENYLENE, PLANT GROWTH REGULATORS | BASF AKTIENGESELLSCHAFT (DE) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184262-A1 | DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF | NPY4R, NPY2R, NPY1R | CYP3A4 1357/4885CA12 1880/4885CA2 1028/4885 |
| US-20230174470-A1 | COMPOUND AS A UBR BOX DOMAIN LIGAND | UBR4, UBQLN2, UBTF | CYP3A4 4471/4885CA12 4586/4885CA2 4852/4885 |
| US-12559455-B2 | Compound as a UBR box domain ligand | UBR4, UBTF, UBQLN1 | CYP3A4 4365/4885CA12 4458/4885CA2 4588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.